The pathological cascade following stroke, including impaired clearance of metabolic byproducts such as β-amyloid (Aβ) (4), tau protein (5), lactate (6) and iron (7), contributes significantly to PSCI pathogenesis, though the underlying mechanisms remain incompletely understood. This evidence concerns the gene MAPT and stroke disorder.